FDA Issues Draft Guidance on Off-Label Use Information Dissemination

The U.S. Food and Drug Administration issued a draft guidance for manufacturers regarding distributing information about off-label uses for their products.

Advertisement

Read the full article on Becker’s Hospital Review.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.